ArticleScientific reports2024

EPLIN, a prospective oncogenic molecule with contribution to growth, migration and drug resistance in pancreatic cancer.

Jianyuan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.